NIH launches study of extra COVID-19 vaccine dose in people with autoimmune disease

Trial also will test pausing immunosuppressive medication to improve antibody response.
Source: National Institutes of Health (NIH) News Releases - Category: American Health Source Type: news

Related Links:

Conclusions: There are no definite correlations to the COVID-19 pandemic or vaccination and new or worsened otologic symptoms. Vaccinated patients with new or exacerbated otologic symptoms should be promptly referred for evaluation. Suspected cases of post-vaccination otologic symptoms should be reported to the Center for Disease Control (CDC) vaccine adverse event reporting system (VAERS).
Source: Otology and Neurotology - Category: ENT & OMF Tags: SENSORINEURAL HEARING LOSS AND TINNITUS Source Type: research
Myasthenia gravis (MG) is an autoimmune disease characterized by muscle weakness and abnormal fatigability due to the antibodies against postsynaptic receptors. Despite the individual discrepancy, patients with MG share common muscle weakness, autoimmune dysfunction, and immunosuppressive treatment, which predispose them to infections that can trigger or exacerbate MG. Vaccination, as a mainstay of prophylaxis, is a major management strategy. However, the past years have seen growth in vaccine hesitancy, owing to safety and efficacy concerns. Ironically, vaccines, serving as an essential and effective means of defense, may...
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
(Natural News) Dr. Ryan Cole, a board-certified pathologist and diagnostics lab owner and operator based out of Idaho, has released shocking new information about how Wuhan coronavirus (Covid-19) “vaccines” are causing a massive “uptick” in autoimmune diseases and cancer. In a video produced by the Idaho state government’s “Capitol Clarity” project, Cole revealed how he...
Source: - Category: Consumer Health News Source Type: news
(Natural News) Investigative journalist Sharyl Attkisson is logging all known cases of Wuhan coronavirus (Covid-19) “vaccine” injury and death in a running list on her website. Some of the latest updates include instances of CNS demyelination, functional neurological disorder, waning immunity, Bell’s palsy, antibody dependent enhancement (ADE), heart disorders, Guillain-Barre autoimmune paralysis, Graves’ disease and...
Source: - Category: Consumer Health News Source Type: news
CONCLUSIONS: Tolerability of COVID-19 mRNA vaccines in patients with TETs is comparable to the general population. Most patients with pre-existing AD did not experience disease flares and the development of new AD was rare. Patients with TETs should be encouraged to get vaccinated against COVID-19 due to the documented benefits of vaccination and manageable risk profile.PMID:34514444 | PMC:PMC8423742 | DOI:10.1016/j.jtocrr.2021.100229
Source: Clinical Lung Cancer - Category: Cancer & Oncology Authors: Source Type: research
Vaccine. 2021 Sep 2:S0264-410X(21)01126-9. doi: 10.1016/j.vaccine.2021.08.078. Online ahead of print.ABSTRACTLittle is known about COVID-19 mRNA vaccine humoral immune responses in patients with central nervous system autoimmune demyelinating diseases, multiple sclerosis (MS) and neuromyelitis optica (NMO), who are on B-cell depleting therapies (BCDT) and other disease modifying therapies (DMTs). We conducted a single center prospective study to identify the clinical and immunological features associated with vaccine-induced antibody response in 53 participants before and after COVID-19 mRNA vaccination. This is the first ...
Source: Vaccine - Category: Allergy & Immunology Authors: Source Type: research
We report clinical and MRI features of seven individuals who received the Moderna (n  = 3) or Pfizer (n  = 4) SARS-CoV-2 mRNA vaccines. Within one to 21  days of either the first (n  = 2) or second (n  = 5) vaccine dose, these patients developed neurologic symptoms and MRI findings consistent with active CNS demyelination of the optic nerve, brain, and/or spinal cord. Symptoms included visual loss, dysmetria, gait instability, paresthesias, sphincter disturbance, and limb weakness. Age ranged from 24 to 64 (mean 39.1) years; five were woman (71.4%). The final dia...
Source: Journal of Neurology - Category: Neurology Source Type: research
MANHASSET, N.Y., Sept. 2, 2021. As part of a new National Institutes of Health (NIH) coronavirus disease 2019 (COVID-19) vaccine clinical trial, The Feinstein Institutes for Medical Research– the science arm of Northwell Health–...
Source: - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials
(Reuters)—The U.S. National Institutes of Health (NIH) is testing a booster shot of COVID-19 vaccines in people with autoimmune diseases who have not responded well to the primary vaccine course. The mid-stage study will be conducted among about 600 participants aged 18 and above who have been fully vaccinated with shots from either Pfizer Inc.,... [Read More]
Source: The Rheumatologist - Category: Rheumatology Authors: Tags: Conditions booster shot COVID-19 National Institutes of Health (NIH) vaccine Source Type: research
CONCLUSION: Although it is a sporadic finding, SARS-CoV-2 can cause transverse myelitis. The condition responds to medical therapy.PMID:34457267 | PMC:PMC8380545 | DOI:10.1016/j.amsu.2021.102749
Source: Annals of Medicine - Category: Internal Medicine Authors: Source Type: research
More News: American Health | Autoimmune Disease | COVID-19 | National Institutes of Health (NIH) | Study | Vaccines